Your browser doesn't support javascript.
loading
Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease.
Gritsch, Herbert; Schrenk, Gerald; Weinhappl, Nina; Mellgård, Björn; Ewenstein, Bruce; Turecek, Peter L.
Affiliation
  • Gritsch H; Pharmaceutical Sciences, Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria.
  • Schrenk G; Pharmaceutical Sciences, Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria.
  • Weinhappl N; Pharmaceutical Sciences, Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria.
  • Mellgård B; Rare Genetics and Hematology, Research & Development, Takeda Development Center Americas, Inc, Cambridge, MA, USA.
  • Ewenstein B; Rare Genetics and Hematology, Research & Development, Takeda Development Center Americas, Inc, Cambridge, MA, USA.
  • Turecek PL; Department of Pharmaceutical Sciences, Division of Pharmacology, University of Vienna, Vienna, Austria.
J Blood Med ; 13: 649-662, 2022.
Article in En | MEDLINE | ID: mdl-36405429
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Blood Med Year: 2022 Document type: Article Affiliation country: Austria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Blood Med Year: 2022 Document type: Article Affiliation country: Austria